Replimune Group Bilan de santé
Santé financière contrôle des critères 5/6
Replimune Group possède un total de capitaux propres de $381.5M et une dette totale de $45.6M, ce qui porte son ratio d'endettement à 11.9%. Son actif total et son passif total sont $498.2M et de $116.7M.
Informations clés
11.9%
Ratio d'endettement
US$45.57m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$432.06m |
| Fonds propres | US$381.46m |
| Total du passif | US$116.74m |
| Total des actifs | US$498.20m |
Mises à jour récentes de la santé financière
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Recent updates
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05Analyse de la situation financière
Passif à court terme: Les actifs à court terme de REPL ( $442.6M ) dépassent ses passifs à court terme ( $43.8M ).
Passif à long terme: Les actifs à court terme de REPL ( $442.6M ) dépassent ses passifs à long terme ( $73.0M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: REPL dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de REPL est passé de 8% à 11.9% au cours des 5 dernières années.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: REPL dispose d'une piste de trésorerie suffisante pour plus d'un an sur la base de son flux de trésorerie disponible actuel.
Prévisions de trésorerie: REPL dispose d'une marge de trésorerie suffisante pour 2.1 ans si le flux de trésorerie disponible continue de diminuer à un taux historique de 30 % chaque année.